You are viewing: Europe Pharmaceutical Manufacturing Equipment Market analysis

The Europe Pharmaceutical Manufacturing Equipment Market was valued at $6578 Million in 2026 and projected to reach to $9382 Million by 2031, representing a compound annual growth rate of 6.1%. Europe's pharmaceutical manufacturing equipment market is positioned for sustained growth through 2031, driven by increasing biopharmaceutical production demands, regulatory compliance requirements, and technological advancement.

Europe Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • This steady expansion reflects Europe's strong regulatory framework, advanced manufacturing capabilities, and significant investment in biopharmaceutical production infrastructure.
  • Europe continues to be a critical hub for pharmaceutical innovation and production, driven by stringent quality standards and the presence of leading pharmaceutical manufacturers across the region. The growth trajectory in Europe is supported by increasing demand for automated and precision manufacturing equipment, particularly in response to rising production volumes and the shift toward continuous manufacturing processes.
  • Europe's pharmaceutical sector is increasingly adopting advanced technologies to enhance efficiency and comply with evolving regulatory requirements.
  • Between 2026 and 2031, Europe is expected to maintain its position as a key market for pharmaceutical manufacturing equipment, with sustained investment in modernization and capacity expansion across member states..

Key Market Statistics

  • CAGR (2026-2031) 6.1% CAGR
  • Market Size, 2026 ~USD 6578 Million
  • Forecast, 2031 ~USD 9382 Million
  • Geography Europe

Europe Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation & Growth :

Europe's pharmaceutical manufacturing equipment market is valued at $6,578 million in 2026 and is projected to reach $9,382 million by 2031, demonstrating a robust 6.1% CAGR that aligns closely with global growth trends.

Regulatory Excellence & Compliance :

Europe's stringent regulatory framework, including EMA guidelines and GMP standards, drives demand for advanced manufacturing equipment that ensures product quality, safety, and compliance across the region's pharmaceutical sector.

Biopharmaceutical Infrastructure Investment :

Significant capital investment in biopharmaceutical production facilities across Europe, particularly in Germany, France, and Italy, is accelerating the adoption of innovative manufacturing technologies and equipment solutions.

Regional Market Leadership :

Germany leads European market expansion with $2,702.1 million in market size, followed by Italy ($1,492.1 million) and France ($1,247.7 million), reflecting strong pharmaceutical manufacturing capabilities and innovation hubs.

Europe Pharmaceutical Manufacturing Equipment Market Dynamics

  • The region's mature healthcare infrastructure and strong investment in R&D facilities support continued market expansion.
  • Key growth drivers include the shift toward personalized medicine, expansion of contract manufacturing organizations (CMOs), and modernization of existing production facilities to meet evolving quality standards. The European market benefits from established supply chains, skilled workforce availability, and proximity to major pharmaceutical markets.
  • Strategic investments in automation, continuous manufacturing technologies, and digital solutions are reshaping the competitive landscape.
  • With Germany, Italy, and France as primary growth engines, Europe is expected to maintain its position as a critical hub for pharmaceutical manufacturing innovation and equipment adoption through 2031..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • Europe's pharmaceutical manufacturing equipment market will grow from $6,578M (2026) to $9,382M (2031) at a 6.1% CAGR.
    • Europe's stringent regulatory environment and advanced manufacturing standards drive demand for high-quality, compliant equipment.
    • Automation and continuous manufacturing adoption are key growth drivers across Europe's pharmaceutical production facilities.
    • Europe maintains its position as a critical global hub for pharmaceutical innovation and equipment investment through 2031.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    Europe Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Equipment Manufacturers & Suppliers : Pharmaceutical equipment manufacturers need Europe-specific market data to identify growth opportunities, benchmark competitive positioning, and develop localized product strategies for Germany, France, and Italy.
    • Pharmaceutical & Biopharmaceutical Companies : Pharma manufacturers require detailed European market insights to plan capital expenditures, facility expansions, and equipment procurement strategies aligned with regional regulatory requirements and production demands.
    • Contract Manufacturing Organizations (CMOs) : CMOs operating in Europe need market forecasts and technology trends to optimize manufacturing capacity investments, upgrade equipment portfolios, and remain competitive in the region's growing biopharmaceutical sector.
    • Investment & Private Equity Firms : Investors evaluating pharmaceutical manufacturing opportunities in Europe require comprehensive market sizing, growth projections, and regional dynamics to assess portfolio companies and identify acquisition targets.
    • Regulatory & Consulting Bodies : Regulatory agencies, consultants, and industry associations need European market data to understand manufacturing trends, compliance challenges, and technology adoption patterns shaping the pharmaceutical equipment landscape.

    Key Companies in the Europe Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 8836.7 Million · 5.6% wtd CAGR ·
    Asia Pacific
    ~USD 10750.5 Million · 6.9% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    UKUSD 1255.3 Million
    GermanyUSD 2702.1 Million
    FranceUSD 1247.7 Million
    ItalyUSD 1492.1 Million
    Rest Of EuropeUSD 2684.7 Million

    Country market size visualization

    UK
    USD 1255.3 Million
    Germany
    USD 2702.1 Million
    France
    USD 1247.7 Million
    Italy
    USD 1492.1 Million
    Rest Of Europe
    USD 2684.7 Million

    Reasons to Buy this Report

    • Country-Level Market Insights : Access detailed market sizing and growth projections for Germany, France, Italy, UK, and Rest of Europe, enabling targeted investment and expansion strategies in high-growth pharmaceutical manufacturing hubs.
    • Regulatory & Compliance Intelligence : Understand how Europe's stringent EMA and GMP regulatory requirements drive equipment demand, helping suppliers align product development with regional compliance standards and market opportunities.
    • Competitive Landscape Analysis : Identify market leaders and emerging players across European pharmaceutical equipment segments, with insights into regional competitive dynamics and market consolidation trends through 2031.
    • Technology & Innovation Trends : Discover adoption rates of automation, continuous manufacturing, and digital solutions across European pharmaceutical facilities, informing product roadmaps and go-to-market strategies.
    • Strategic Growth Planning : Leverage 6.1% CAGR projections and regional market forecasts to develop evidence-based business strategies, partnership opportunities, and investment decisions in Europe's pharmaceutical manufacturing sector.

    Frequently asked questions

    What is the current size of Europe's pharmaceutical manufacturing equipment market?

    Europe's pharmaceutical manufacturing equipment market is valued at $6,578 million in 2026 and is expected to reach $9,382 million by 2031.

    What is the projected growth rate for Europe's pharmaceutical manufacturing equipment market?

    Europe's pharmaceutical manufacturing equipment market is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2031.

    What factors are driving growth in Europe's pharmaceutical manufacturing equipment market?

    Key drivers include Europe's stringent regulatory requirements, increasing automation adoption, the shift toward continuous manufacturing, and sustained investment in biopharmaceutical production capacity.

    Which countries in Europe are leading the pharmaceutical manufacturing equipment market?

    Europe's pharmaceutical manufacturing equipment market is led by countries with strong pharmaceutical sectors, including Germany, Switzerland, France, and the United Kingdom, which host major pharmaceutical manufacturers and research facilities.

    How is Europe's pharmaceutical manufacturing equipment market expected to evolve by 2031?

    By 2031, Europe's market is expected to see increased adoption of advanced automation technologies, greater emphasis on compliance with evolving regulations, and continued investment in modernizing production facilities across the region.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status